A new post-treatment method for lead–tin mixed perovskites enabling device fill factors approaching 83%.
No takes yet. Share an insight, caveat, or question.
Jayawardena et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: